PARM1 anticorps (AA 201-310)
Aperçu rapide pour PARM1 anticorps (AA 201-310) (ABIN872651)
Antigène
Voir toutes PARM1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 201-310
-
Homologie
- Human
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human Cipar1
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Date de péremption
- 12 months
-
-
- PARM1 (Prostate Androgen-Regulated Mucin-Like Protein 1 (PARM1))
-
Autre désignation
- Cipar1
-
Sujet
-
Synonyms: Alternative namesCastration induced prostatic apoptosis related protein 1, Cipar 1, Cipar-1, Prostatic androgen repressed message 1 protein, Protein PARM 1 Precursor,PARM1_HUMAN.
Background: Cipar1 may be involved in a survival program enabling certain prostatic cells to resist apoptosis. It is expressed in prostate and detected in other organs at low levels, these include the heart and various tissues of the urogenital tract, not detected in mammary gland.
Antigène
-